Sign Out
Hypersensitivity to somatropin or to any of the excipients.
ZOMACTON must not be used when there is any evidence of activity of a tumour. Intracranial tumours must be inactive and antitumor therapy must be completed prior to starting GH therapy. Treatment should be discontinued if there is evidence of tumour growth.
ZOMACTON should not be used for growth promotion in children with closed epiphysis.
Patients with acute critical illness suffering complications following open heart surgery, abdominal surgery, multiple accidental trauma, acute respiratory failure, or similar conditions should not be treated with ZOMACTON (see Precautions).
In children with chronic renal disease, treatment with ZOMACTON should be discontinued at renal transplantation.
ZOMACTON 4 mg must not be given to premature babies or neonates as the solvent contains benzyl alcohol.
